一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>121104-96-9

121104-96-9

中文名稱 CELGOSIVIR
英文名稱 celgosivir
CAS 121104-96-9
分子式 C12H21NO5
分子量 259.3
MOL 文件 121104-96-9.mol
121104-96-9 結(jié)構(gòu)式 121104-96-9 結(jié)構(gòu)式

基本信息

中文別名
西戈斯韋
化合物 T10755L
CELGOSIVIR, Α-葡萄糖苷酶抑制劑
英文別名
BuCast
MX3253
MBI 3253
MDL 28574
celgosivir
Celgosivir (free base)
6-O-butyl castanospermine
6-Butyryl castanospermine
Castanospermine 6-butyrate
MDL28574
MDL-28574
MDL 28574
所屬類別
生物化工:激動劑抑制劑

物理化學(xué)性質(zhì)

熔點(diǎn)114-115 °C
沸點(diǎn)422.9±45.0 °C(Predicted)
密度1.33±0.1 g/cm3(Predicted)
儲存條件Hygroscopic, -20°C Freezer, Under inert atmosphere
溶解度Chloroform (Slightly), DMSO (Slightly)
酸度系數(shù)(pKa)13.14±0.70(Predicted)
形態(tài)Solid
顏色White to Pale Beige
水溶解性H2O: 2mg/mL, clear
穩(wěn)定性Hygroscopic
InChI1S/C12H21NO5/c1-2-3-9(15)18-8-6-13-5-4-7(14)10(13)12(17)11(8)16/h7-8,10-12,14,16-17H,2-6H2,1H3/t7-,8-,10+,11+,12+/m0/s1
InChIKeyHTJGLYIJVSDQAE-VWNXEWBOSA-N
SMILESO[C@@H]1[C@@H](OC(CCC)=O)CN2[C@@]([C@@H](O)CC2)([H])[C@H]1O

安全數(shù)據(jù)

危險(xiǎn)性符號(GHS)有害 (GHS07)
GHS07
警示詞警告
危險(xiǎn)性描述H302-H315-H319-H335
WGK GermanyWGK 3
存儲類別11 - Combustible Solids
CELGOSIVIR價(jià)格(試劑級)
報(bào)價(jià)日期產(chǎn)品編號產(chǎn)品名稱CAS號包裝價(jià)格
2026/06/05HY-16134CELGOSIVIR
Celgosivir
121104-96-95 mg1700元
2026/06/05HY-16134CELGOSIVIR
Celgosivir
121104-96-910 mg2750元
2026/06/05HY-16134CELGOSIVIR
Celgosivir
121104-96-925 mg5800元

常見問題列表

生物活性
Celgosivir (MBI 3253; MDL 28574; MX3253) 是 α-葡萄糖苷酶 I (α-glucosidase I) 抑制劑,在體外實(shí)驗(yàn)中的 IC50 值為 1.27 μM。
靶點(diǎn)

IC50: 1.27 μM (α-glucosidase I)

體外研究

Celgosivir is more effective (IC 50 =20 μM) than the parent molecule (IC 50 =254 μM) at causing the accumulation of glucosylated oligosaccharides in HIV-infected cells by inhibition of glycoprotein processing. Celgosivir exhibits potent antiviral activity against HIV-1 with an IC 50 of 2.0±2.3 μM. Bovine viral diarrhoea virus (BVDV) is a closely related virus of hepatitis C virus (HCV). Celgosivir inhibits BVDV with IC 50 values of 16 and 47 μM in plaque assay and cytopathic effect assay, respectively. Celgosivir inhibits DENV2 replication with an EC 50 of 0.2 μM. The EC 50 values against DENV1, 3 and 4 are less than 0.7 μM.

體內(nèi)研究

Celgosivir fully protects AG129 mice from lethal infection with a mouse adapted dengue virus at a dose of 50 mg/kg twice daily (BID) for 5 days and is effective even after 48 h delayed treatment. The protection by celgosivir is dose- and schedule-dependent and that a twice-a-day regimen of 50, 25 or 10 mg/kg is more protective than a single daily dose of 100 mg/kg. Pharmacokinetics studies of celgosivir in mice shows that it rapidly metabolizes to castanospermine. During primary infection with a mouse-adapted DENV strain S221, mice shows increased viremia on day 3, yet 80% survived day 10 with virus completely cleared by day 8.

"121104-96-9" 相關(guān)產(chǎn)品信息
79831-76-8
泗阳县| 建始县| 长泰县| 韶山市| 东丰县| 治多县| 和龙市| 筠连县| 岱山县| 嘉祥县| 阿克| 丹东市| 南安市| 安龙县| 中宁县| 山东| 瓦房店市| 武功县| 卓资县| 镇赉县| 友谊县| 兴城市| 包头市| 彰化县| 昔阳县| 泸西县| 张家界市| 钟山县| 清远市| 茂名市| 茌平县| 七台河市| 怀来县| 乃东县| 抚州市| 怀仁县| 盐源县| 通许县| 贵南县| 涡阳县| 临夏市|